Galmed Pharmaceuticals Acquires Colospan to Build GI-Focused Medtech and Biopharmaceutical Platform

Apax Partners and Fremman Capital acquire co-controlling stakes in Palex Medical

August 1, 2023

Medical Devices

Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.

Collagen Matrix Acquires Polyganics

October 5, 2022

Medical Devices

Collagen Matrix, a Linden Capital Partners portfolio company, has acquired Polyganics B.V., a Netherlands-based developer and manufacturer of bioresorbable medical devices. The add-on acquisition expands Collagen Matrix's regenerative medicine and polymer capabilities, entering new clinical verticals such as ENT and general surgery and broadening its neurosurgery and peripheral nerve offerings.

Coloplast to Acquire Atos Medical from PAI Partners for c. €2.2 billion

November 8, 2021

Medical Devices

Coloplast has agreed to acquire Atos Medical from private equity firm PAI Partners for an enterprise value of approximately €2.2 billion. Atos Medical, headquartered in Malmö, Sweden, is a global leader in laryngectomy and tracheostomy products with ~1,150 employees and a direct presence in 30 countries; the deal is subject to customary regulatory approvals and was anticipated to close in Q1 2022.

Fremman Acquires Majority Stake in Palex from Ergon and Corpfin

October 20, 2021

Medical Devices

Fremman has acquired a majority stake in Palex, the leading distributor of high value-added MedTech equipment and solutions in Spain and Portugal, from Ergon Capital Partners and Corpfin Capital. Management, Ergon and Corpfin will remain minority shareholders as Fremman partners with the Palex team to pursue further consolidation and geographic expansion across Iberia and Europe.

Galecto Inc. Merges with San Diego-based PharmAkea, Inc.

January 9, 2020

Pharmaceuticals

Copenhagen-headquartered Galecto Inc. (a Novo Seeds portfolio company) has merged with San Diego-based PharmAkea, Inc. The combined clinical-stage company will retain the Galecto name, be incorporated in the United States, and combine complementary pipelines in fibrosis and oncology to accelerate development of small-molecule and galectin-targeting therapeutics.

Boston Scientific Acquires Xlumena

April 1, 2015

Medical Devices

Boston Scientific agreed to acquire Mountain View–based medical device company Xlumena, gaining the AXIOS and HOT AXIOS stent and delivery systems. The deal includes $62.5 million upfront, $12.5 million contingent on FDA clearance of HOT AXIOS and additional sales-based milestones, and is intended to expand Boston Scientific's endoscopy and EUS therapeutic capabilities and accelerate global commercialization of the AXIOS platform.